Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Aleplasinin (PAZ 417) is a selective and orally active inhibitor of Plasminogen activator inhibitor-1(PAI-1) and a key negative regulator of the fibrinolytic system. Aleplasinin can be used in Alzheimer's disease studies.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 125.00 | |
5 mg | In stock | $ 313.00 | |
10 mg | In stock | $ 513.00 | |
25 mg | In stock | $ 837.00 | |
50 mg | In stock | $ 1,160.00 | |
100 mg | In stock | $ 1,560.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 363.00 |
Description | Aleplasinin (PAZ 417) is a selective and orally active inhibitor of Plasminogen activator inhibitor-1(PAI-1) and a key negative regulator of the fibrinolytic system. Aleplasinin can be used in Alzheimer's disease studies. |
Synonyms | PAZ 417, PAZ417, PAZ-417 |
Molecular Weight | 425.52 |
Formula | C28H27NO3 |
CAS No. | 481629-87-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 245 mg/mL (575.77 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Aleplasinin 481629-87-2 Metabolism PAI-1 Plasminogen activator inhibitor-1 Serpin family PAZ 417 Abeta inhibit PAZ417 Inhibitor Amyloid-β Alzheimer's disease BBB-penetrated β-amyloid peptide orally active PAZ-417 memory deficiency inhibitor